Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Targeted Search
Clinical Trials Search Results
Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]UCB"
Count: 615
Selected: 0
| NCT ID | Title |
|---|
| NCT01964560 | A Clinical Study to Investigate the Efficacy and Safety of Lacosamide as an Add on Therapy in Children With Epilepsy With Partial-onset Seizures | ||
| NCT01832038 | Study to Evaluate the Safety, Tolerability, and Efficacy of Long-term Adjunctive Therapy With Lacosamide in Adults With Partial-onset Seizures | ||
| NCT01646255 | Rotigotine Versus Placebo, A Study To Evaluate The Efficacy In Advanced Stage Idiopathic Parkinson's Disease Patients | ||
| NCT01710657 | A Trial to Evaluate the Efficacy and Safety of Adjunctive Therapy With Lacosamide in Adults With Partial-Onset Seizures | ||
| NCT00600509 | Bridging Study of L059 (Levetiracetam) in Patients With Epilepsy by Double Blind Method | ||
| NCT01261325 | Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures | ||
| NCT00464269 | Double-blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures | ||
| NCT00152477 | A Study of Paclitaxel/Carboplatin With or Without CDP791 in Patients With Lung Cancer | ||
| NCT00175916 | Follow-up Trial to Evaluate Long-term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy | ||
| NCT01190410 | Extension Study to Assess Long Term Safety in Children and Adolescents With Crohn's Disease Receiving Certolizumab Pegol | ||
| NCT05028127 | A Study to Evaluate the Relative Bioavailability and Tolerability of Bimekizumab in Healthy Subjects | ||
| NCT01261793 | Study of Epratuzumab Versus Placebo in Subjects With Moderate to Severe General Systemic Lupus Erythematosus (SLE) | ||
| NCT00160602 | A Study of Liquid Certolizumab Pegol as Additional Medication to Methotrexate in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid Arthritis | ||
| NCT00152386 | A Placebo Controlled Study to Assess Efficacy and Safety of Certolizumab Pegol in the Treatment of Rheumatoid Arthritis | ||
| NCT00175890 | A Placebo-controlled Study of Levetiracetam In Children (1mo to 4yrs of Age) With Partial Onset Seizures. | ||
| NCT00844285 | SECURE, the Cimzia ® Crohn's Disease Post-Marketing Registry | ||
| NCT00160654 | Open Label Safety and Efficacy Study of Levetiracetam in Patients With Epilepsy | ||
| NCT00291668 | Clinical Study of CDP870/Certolizumab Pegol in Patients With Active Crohn's Disease | ||
| NCT00615615 | Efficacy and Tolerability of Levetiracetam Add-On Treatment in Refractory Pediatric Patients With Partial Onset Seizures | ||
| NCT01095393 | National Data Bank for Rheumatic Disease Registry Study of Safety in Patients With Rheumatoid Arthritis Treated With Cimzia® or Disease-modifying Antirheumatic Drugs (DMARDs) | ||
| NCT00621959 | A Study Evaluating the Efficacy and Impact on Health-related Quality of Life of Levocetirizine in Adults With Seasonal Allergic Rhinitis | ||
| NCT00368069 | A Study to Look at the Efficacy and Safety of Keppra® Extended Release Formulation - XR | ||
| NCT00160641 | A Study of the Safety and Effectiveness of Liquid Certolizumab Pegol in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid Arthritis | ||
| NCT00175877 | A Study of the Safety and Effectiveness of Lyophilized Certolizumab Pegol in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid Arthritis | ||
| NCT02610543 | UCB Proof of Concept Study in Patients With Primary Sjögren's Syndrome | ||
| NCT01009242 | To Evaluate the Blood Levels and Safety of IV and Subcutaneous CDP6038 in Subjects With Rheumatoid Arthritis Using Methotrexate | ||
| NCT01969851 | A Study to Investigate the Safety and Efficacy of Lacosamide Added to the Patients Current Therapy in Patients Aged 1 Month to Less Than 18 Years Old With Epilepsy Syndromes Associated With Generalized Seizures. | ||
| NCT00329303 | Efficacy of Re-treatment With Cimzia® in Subject With Chronic Plaque Psoriasis | ||
| NCT00245765 | Efficacy Study of CDP870 in Subjects With Chronic Plaque Psoriasis Who Are Candidate for Systemic Therapy and/or Phototherapy/Photochemotherapy | ||
| NCT00938431 | A Multicenter, Open-Label Study To Investigate The Safety And Pharmacokinetics Of Lacosamide In Children With Partial Seizures | ||
| NCT00160667 | A Study Assessing Efficacy of Brivaracetam in Subjects With Persistent Pain After Shingles (Post-herpetic Neuralgia) | ||
| NCT01408576 | Open Label Extension Study of Epratuzumab in Subjects With Systemic Lupus Erythematosus | ||
| NCT00175825 | A Dose-ranging Study With Brivaracetam in Patients From 16 to 65 Years With Refractory Partial Onset Seizures. | ||
| NCT01262365 | Study of Epratuzumab Versus Placebo in Subjects With Moderate to Severe General Systemic Lupus Erythematosus | ||
| NCT00291642 | A Study to Compare the Efficacy of Levocetirizine to Placebo in Reducing Symptoms of Seasonal Allergic Rhinitis (SAR) in Sensitive Subjects Exposed to Ragweed Pollen | ||
| NCT00599339 | Transdermal Rotigotine User Surveillance Study | ||
| NCT00552058 | Study to Evaluate Efficacy and Safety of Certolizumab Pegol for Induction of Remission in Patients With Crohn's Disease | ||
| NCT00356408 | Examining the Long Term Safety, Efficacy, and Corticosteroid-sparing Effect of Certolizumab Pegol in Crohn's Disease | ||
| NCT00349752 | Corticosteroid Sparing Effect of Certolizumab in Crohn's Disease | ||
| NCT00333788 | Follow-up to Welcome Study C87042 [NCT00308581] Examining Certolizumab Pegol (CDP870) in Subjects With Crohn's Disease | ||
| NCT00308581 | Certolizumab in Crohn's Disease Patients With Loss of Response or Intolerance to Infliximab | ||
| NCT00580840 | Dosing Flexibility Study in Patients With Rheumatoid Arthritis | ||
| NCT01292265 | A 12 Week Study to Assess Changes in Joint Inflammation Using Ultrasonography in Patients With Rheumatoid Arthritis (RA) | ||
| NCT00993668 | Assessing the Use of Certolizumab Pegol in Adult Subjects With Rheumatoid Arthritis on the Antibody Response When Receiving Influenza Virus and Pneumococcal Vaccines | ||
| NCT00753454 | Open Label Extension for Patients Coming From the Dosing Flexibility Study in Patients With Rheumatoid Arthritis (RA) | ||
| NCT00717236 | Certolizumab Pegol for the Treatment of Patients With Active Rheumatoid Arthritis | ||
| NCT00160693 | Open Label Long-Term Safety Study of Certolizumab Pegol (CZP) for Patients With Rheumatoid Arthritis | ||
| NCT01521923 | A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drugs (DMARD)-naïve Adults With Early Active Rheumatoid Arthritis | ||
| NCT01255761 | A Comparison of Two Assessment Tools in Predicting Treatment Success of Cimzia in Rheumatoid Arthritis Subjects | ||
| NCT01921205 | Study to Investigate Lacosamide as Add-on Therapy in Subjects ≥4 Years to <17 Years of Age With Partial Onset Seizures |
